Colloid solutions for fluid resuscitation

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2012, Pages

  Bunn, Frances ^a   Trivedi, Daksha ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH; PLASMA PROTEIN FRACTION;

ANAPHYLAXIS; BLOOD TRANSFUSION; BLOOD VOLUME; COLLOID; CRITICALLY ILL PATIENT; DRUG HYPERSENSITIVITY; FLUID RESUSCITATION; HUMAN; HYPOVOLEMIA; INFORMATION PROCESSING; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SURGICAL PATIENT; SYSTEMATIC REVIEW;

EID: 84974586110     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001319.pub5     Document Type: Review

References (142)

1. Akech S, Gwer S, Idro R, Fegan G, Eziefula AC, Newton CRJC, et al. Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Hub for Clinical Trials 2006;1(5):e21.
2. Allison KP, Gosling P, Jones S, Pallister I, Porter K. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. Journal of Trauma 1999;47(6):1114-21.
3. Arellano R, Gan BS, Salpeter MJ, Yeo E, McCluskey S, Pinto R, et al. A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery. Anesthesia and Analgesia 2005;100:1846-53.
4. Asfar P, Kereni N, Labadie F, Gouello JP, Brenet O, Alquier P. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Medicine 2000;26(9):1282-7.
5. Beards SC, Watt T, Edwards JD, Nightingale P, Farragher EB. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill patients: a prospective, randomized trial. Critical Care Medicine 1994;22(4):600-5. [MEDLINE: 1994192356]
6. Berard JP, Curt I, Piech JJ, Ruiz F. Hydroxyethylamidons versus gelatines: impact on the cost of replacement in an emergency (resuscitation) service [Hydroxyethylamidons versus gelatines: impact sur le cout du rempissage dans un service de reanimation]. Annales Francaises d'Anaesthesia et de Reanimation 1995;14:R335.
7. Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, et al. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. British Journal of Anaesthesia 1997;78(1):44-50. [MEDLINE: 1997212347]
8. Boldt JV, Von Bormann B, Kling D, Borner U, Mulch J, Hempelmann G. Volume replacement with a new hydroxyethyl starch preparation (3% HES 200/0.5) in heart surgery [Volumenersatz mit einem neuen hydroxyathylstarke - praparat (3% HAS 200/0.5) in der herzchirurgie]. Infusionstherapie und Klinische Ernahrung 1986;13(3):145-51. [MEDLINE: 1986302988]
9. Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesthesia and Analgesia 1993;76(6):1185-90.
10. Boldt J, Heesen M, Welters I, Padberg W, Martin K, Hempelmann G. Does the type of volume therapy influence endothelial-related coagulation in the critically ill?. British Journal of Anaesthesia 1995;75(6):740-6. [MEDLINE: 1996246804]
11. Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesthesia and Analgesia 1996;83(2):254-61. [MEDLINE: 1996302067]
12. Boldt J, Heesen M, Padberg W, Martin K, Hempelmann G. The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients. Anaesthesia 1996;51(6):529-35. [MEDLINE: 1996296856]
13. Boldt J, Mueller M, Menges T, Papsdorf M, Hempelmann G. Influence of different volume therapy regimens on regulators of the circulation in the critically ill. British Journal of Anaesthesia 1996;77(4):480-7. [MEDLINE: 1997097789]
14. Boldt J, Muller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: is there a difference?. Intensive Care Medicine 1998;24(1):28-36. [MEDLINE: 1998163949]
15. Boldt J, Suttner S, Kumle B, Huttner I. Cost analysis of different volume replacement strategies in anesthesia. Infusionstherapie und Transfusionsmedizin 2000;27(1):38-43.
16. Boldt J, Suttner S, Huttner I, Kumle B, Piper S, Krumholz W. Are cost of a crystalloid-based volume replacement regimen lower than of a colloid-based volume replacement strategy?. Infusionstherapie und transfusionsmedizin 2001;28(3):144-9.
17. Brock H, Rapf B, Necek S, Gabriel C, Peterlik C, Polz W. Volume replacement after cardiac surgery. A comparison of small-volume resuscitation and two different colloid solutions [Vergleichende untersuchungen zur postoperativen volumentherapie]. Anaesthesist 1995;44(7):486-92. [MEDLINE: 1995390424]
18. Brutocao D, Bratton SL, Thomas JR, Schrader PF, Coles PG, Lynn AM. Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 1996;10(3):348-51. [MEDLINE: 1996298754]
19. Carli P, Goldstein P, Lejay M, Facon A, Orliaguet G, Petit P. Prehospital care of hypovolemic trauma patients: 6% hydroxyethyl starch versus gelatin [Remplissage vasculaire prehospitalier en traumatologie: Hesteril 6% versus Plasmion]. Journal Europeen des Urgences 2000;13(1-2):101-5.
20. Claes Y, Van Hemelrijck J, Van Gerven M, Arnout J, Vermylen J, Weidler B, et al. Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anesthesia and Analgesia 1992;75(1):24-30. [MEDLINE: 1992312872]
21. Diehl JT, Lester JL, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Annals of Thoracic Surgery 1982;34(6):674-9. [MEDLINE: 1983073643]
22. Dolecek M, Svoboda P, Kantorova I, Scheer P, Sas I, Bibrova J, et al. Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepato-Gastroenterology 2009;56(96):1622-8.
23. Du Gres B, Gruner MC, Flamens C. A comparison of the hemodynamic effect of Haemaccel and diluted albumin in the immediate postoperative period after heart surgery [Comparaison des effets hemodynamiques de l'Haemaccel et de l'albumine diluee dans la periode postoperatoire immediate apres chirurgie cardiaque]. Cahiers d'Anesthesiologie 1989;37(5):327-32. [MEDLINE: 1990029584]
24. Dytkowska B, Karwacki Z, Suchorzewska J, Wujtewicz M. Comparative assessment of 200/0.5 HAES 6% and Gelafundin in the treatment of hypovolaemia in post-coronary bypass patients. Medical Science Monitor 1998;4(6):1000-3.
25. Evans PA, Heptinstall S, Crowhurst EC, Davies T, Glenn JR, Madira W, et al. Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. Journal of Thrombosis and Haemostasis 2003;1:2140-8.
26. Falk JL, Rackow EC, Astiz ME, Weil MH. Effects of hetastarch and albumin on coagulation in patients with septic shock. Journal of Clinical Pharmacology 1988;28(5):412-5. [MEDLINE: 1988273726]
27. Friedman G, Jankowski S, Shahla M, Gomez J, Vincent JL. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients. Journal of Clinical Anesthesia 2008;20(7):528-33.
28. Fries D, Streif W, Margreiter J, Klingler A, Kühbacher G, Schobersberger W, et al. The effects of perioperative administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis. Blood Coagulation and Fibrinolysis 2004;15:213-9.
29. Fulachier V, Sicard MP, Baille Y, Auffray JP. Effects of fluid expansion using albumin or hydroxyethylstarch on oxygen transport after induction of anesthesia for cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 1994;8(3Supp2):89.
30. Gahr R, Bock PR. Effect of hydroxyethyl starch HES 450/0.7 and 5% human albumin on the colloid osmotic pressure and hemodynamic parameters in hypovolemic patients after major abdominal procedures [Wirkung von hydroxyathylstarke HAS 450/0.7 und humanalbumin 5% auf den kolloidosmotischen druck und hamodynamische parameter bei hypovolamischen patienten nach grosseren abdominalen eingriffen]. Infusionstherapie und Transfusionsmedizin 1981;8(3):147-52. [MEDLINE: 1981262968]
31. Gallagher JD, Moore RA, Kerns D, Jose AB, Botros SB, Flicker S, et al. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesthesia and Analgesia 1985;64(8):753-8.
32. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. European Journal of Anaesthesiology 2008;25(12):986-94.
33. Gold MS, Russo J, Tissot M, Weinhouse G, Riles T. Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. Annals of Surgery 1990;211(4):482-5. [MEDLINE: 1990210743]
34. Gombocz K, Beledi A, Alotti N, Kecskes G, Gabor V, Bogar L, et al. Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia-reperfusion following cardiac operations. Critical Care 2007;11(4):R87. [DOI: 10.1186/cc6095]
35. Gondos T, Marjanek Z, Ulakcasi Z, Szabo Z, Bogar L, Karolyi M, et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. European Journal of Anaesthesiology 2010;27:794-800.
36. Gondos T, Marjanek Z, Ulakcsai Z, Szabó Z, et al. Evaluation of the effectiveness of different volume replacement therapies in postoperative hypovolemic patients using the PiCCO monitoring system. Critical Care 2009;13(1):Suppl 1: P220.
37. Haas T, Preinreich A, Oswald E, Pajk W, Berger J, Kuehbacher G, et al. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 2007;62(10):1000-7.
38. Hausdorfer J, Hagemann H, Heine J. Comparison of volume substitutes human albumin 5% and hydroxyethyl starch 6% in paediatric anaesthesia [Vergleich der volumenersatzmittel humanalbumin 5% und hydroxathylstarke 6% (40.000/0.5) in der kinderanasthesie]. Anasthesie, Intensivtherapie, Notfallmedizin 1986;21(3):137-42. [MEDLINE: 1986320933]
39. Hecht-Dolnik M, Barkan H, Taharka A, Loftus J. Hetastarch increases the risk of bleeding complications in patients after off-pump bypass surgery: a randomized clinical trial. Journal of Thoracic and Cardiovascular Surgery 2009;138:703-11.
40. Hedstrand U, Hogman C, Zaren B, Lundkvist B. Postoperative complications after blood replacement with or without plasma. Acta Chirurgica Scandinavica 1987;153(9):501-5.
41. Hiippala S, Linko K, Myllyla G, Lalla M, Hekali R, Makelainen A. Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiologia Scandinavica 1995;39(2):228-35. [MEDLINE: 1995313480]
42. Huang Y, Yan B, Yang Z. Clinical study of a formula for delayed rapid fluid resuscitation for patients with burn shock. Burns 2005;31:617-22.
43. Huskisson L, Elliott M, Spitz L. Haemodynamic effects of three colloids following pediatric open heart surgery. Clinical Intensive Care 1993;4:302.
44. Inal MT, Memi, Karamanlioglu B, Sut N. Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients. Journal of Critical Care 2010;25(2):361.
45. Jin SL, Yu BW. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(1):91-8.
46. Jones S, Whitten C, Monk T. Influence of crystalloid and colloid replacement solutions on hemodynamic variables during acute normovolemic hemodilution. Journal of Clinical Anaesthesia 2004;16:11-7.
47. Karanko MS. Effects of three colloid solutions on plasma volume and hemodynamics after coronary bypass surgery. Critical Care Medicine 1987;15(11):1015-21. [MEDLINE: 1988054051]
48. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Annals of Thoracic Surgery 1984;37(1):40-6. [MEDLINE: 1984103384]
49. Lisander B, Jacobsson SA, Ivarsson I, Vegfors M, Engdahl O. Giving both enoxaparin and dextran increases the need for transfusion in revision hip arthroplasty. European Journal of Surgery 1996;162(11):861-6. [MEDLINE: 1997115584]
50. London MJ, Ho JS, Triedman JK, Verrier ED, Levin J, Merrick SH, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. Journal of Thoracic and Cardiovascular Surgery 1989;97(5):785-97. [MEDLINE: 1989218083]
51. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. The British Journal of Surgery 2007;94(4):427-33. [PUBMED: 17380548]
52. Mastroianni L, Low HB, Rollman J, Wagle M, Bleske B, Chow MS. A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. Journal of Clinical Pharmacology 1994;34(1):34-40. [MEDLINE: 1994179580]
53. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesthesia and Analgesia 2007;105(4):905-17. [PUBMED: 17898365]
54. Moggio RA, Rha CC, Somberg ED, Praeger P, Pooley RW, Reed GE. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Critical Care Medicine 1983;11(12):943-5. [MEDLINE: 1984056648]
55. Molnar Z, Mikor A, Leiner T, Szakmany T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Medicine 2004;30:1356-60.
56. Mukhtar A, Aboulfetouh F, Obayah G, Salah M, Emam M, Khater Y, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesthesia and Analgesia 2009;109:924-30.
57. Munoz E, Raciti A, Dove D, Stahl WM, Del Guercio L. Effect of hydroxyethyl starch versus albumin on hemodynamic and respiratory function in patients with shock. Critical Care Medicine 1980;8(4):255.
58. Munsch CM, MacIntyre E, Machin SJ, Mackie IJ, Treasure T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. British Journal of Surgery 1988;75(7):675-8. [MEDLINE: 1988327292]
59. Kuitunen A, Suojaranta-Ylinen R, Kukkonen S, Niemi T. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery. Scandinavian Journal of Surgery 2007;96:72-8.
60. Niemi T, Suojaranta-Ylinen R, Kukkonen S, Kuitunen A. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesthesia and Analgesia 2006;102:998-1006.
61. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?. Asian Cardiovascular & Thoracic Annals 2009;17(4):368-72.
62. Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P. Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. Journal of Clinical Anesthesia 1990;2(5):317-23. [MEDLINE: 1991104037]
63. Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine 1983;11(11):839-50. [MEDLINE: 1984027713]
64. Rackow EC, Mecher C, Astiz ME, Griffel M, Falk JL, Weil MH. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Critical Care Medicine 1989;17(5):395-8. [MEDLINE: 1989209912]
65. Reine PA, Kongsgaard UE, Andersen A, Thogersen AK, Olsen H. Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES. Acta Anaesthesiologica Scandinavica 2008;52(3):406-12.
66. Rittoo D, Gosling P, Burnley S, Bonnici C, Millns P, Simms MH, et al. Randomized study comparing the effects of hydroxyethyl starch solution with Gelofusine on pulmonary function in patients undergoing abdominal aortic aneurysm surgery. British Journal of Anaesthesia 2004;92:61-6.
67. Rosencher N, Vassilieff N, Guigonis V, Toulin P, Conseiller C. Comparison of effects of Elohes and albumin on haemostasis in orthopedic surgery [Comparaison des effets de l'Elohes et de l'albumine sur l'hemostase en chirurgie orthopedique]. Annales francaises d'Anesthesie et de Reanimation 1992;11(5):526-30. [MEDLINE: 1993118965]
68. Schortgen F, Lacherade J, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357(9260):911-6.
69. Niemi T, Schramko A, Kukkonen S, Kuitunen A, Suojaranta-Ylinen R. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scandinavian Journal of Surgery 2008;97:259-65.
70. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Kukkonen S, Niemi T. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesthesia and Analgesia 2009;108:30-6.
71. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Comparison of the effect of 6% hydroxyethyl starch and gelatine on cardiac and stroke volume index: a randomized, controlled trial after cardiac surgery. Perfusion 2010;25(5):283-91.
72. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. British Journal of Anaesthesia 2010;6:691-7.
73. Shatney CH, Deepika K, Militello PR, Majerus TC, Dawson RB. Efficacy of hetastarch in the resuscitation of patients with multisystem trauma and shock. Archives of Surgery 1983;118(7):804-9. [MEDLINE: 1983230251]
74. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. European Journal of Anaesthesiology 2008;25(6):437-45.
75. Stockwell MA, Scott A, Day A, Riley B, Soni N. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline: 2. Serum albumin concentration and incidences of pulmonary oedema. Anesthesia 1992;47(1):7-9.
76. Stockwell MA, Soni N, Riley B. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline: 1. Outcome and duration of stay in the intensive care unit. Anaesthesia 1992;47(1):3-6. [MEDLINE: 1992161241]
77. Stoddart PA, Rich P, Sury MR. A comparison of 4.5% human albumin solution and haemaccel in neonates undergoing major surgery. Paediatric Anaesthesia 1996;6(2):103-6. [MEDLINE: 1996243349]
78. Svennevig JL, Tollofsrud S, Kongsgaard U, Noddeland H, Mohr B, Ozer M, et al. Complement activation during and after open-heart surgery is only marginally affected by the choice of fluid for volume replacement. Perfusion 1996;11(4):326-32.
79. Tollofsrud S, Svennevig JL, Breivik H, Kongsgaard U, Ozer M, Hysing E, et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiologica Scandinavica 1995;39(5):671-7.
80. Van der Linden PJ, De Hert SG, Daper A, Trenchant A, Schmartz D, Defrance P, et al. 3.5% Urea linked gelatine is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Canadian Journal of Anaesthesia 2004;51(3):236-41.
81. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesthesia and Analgesia 2005;101:629-34.
82. Veneman T, Oude Nijhuis J, Woittiez A. Human albumin and starch administration in critically ill patients: a prospective RCT. Wiener Klinische Wochenschrift 2004;116(9-10):283-5.
83. Verheij J, van Lingen A, Beishuizen A, Christiaans H, de Jong J, Girbes A, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Medicine 2006;32:1030-8.
84. Verheij J, van Lingen A, Raijmakers P, Rijnsburgr E, Veerman D, Wisselink W, et al. Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. British Journal of Anaesthesia 2006;96(1):21-30.
85. Vogt N, Bothner U, Georgieff M. Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions [Vergleich von humanalbumin 5% und 6% HES 200/0.5 als ausschliessliche kolloidkomponente bei grossen chirurgischen eingriffen]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 1994;29(3):150-6.
86. Vogt NH, Bothner U, Lerch G, Linder KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesthesia and Analgesia 1996;83(2):262-8. [MEDLINE: 1996302068]
87. Vogt N, Bothner U, Brinkmann A, De Petriconi R, Georgieff M. Peri-operative tolerance to large-dose 6% HES 200/0.5 in major urological procedures compared with 5% human albumin. Anaesthesia 1999;54(2):121-7.
88. Vogt N, Bothner U, Lerch G, Georgieff M. Pharmacokinetic and oncotic characteristics of high-dose hydroxyethyl starch compared with human albumin 5% in operative procedures [Pharmakokinetik und onkotisches verhalten von hochdosierter hydroxyathylstarke bei operativen eingriffen im vergleich zu humanalbumin 5%]. Infusion Therapy and Transfusion Medicine 1998;25:212-21.
89. Volta CA, Alvisi V, Campi M, Marangoni E, Alvisi R, Castellazzi M, et al. Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study. Anesthesiology 2007;106(1):85-91. [PUBMED: 17197849]
90. Von Sommoggy S, Fraunhofer J, Jelen-Esselborn S, Stemberger A. Coagulation changes during aortofemural bifurcation bypass: is volume and plasma substitution possible with hydroxyethyl starch alone? [Gerinnungsveranderungen bei aortofemoralem bifurkationsbypass: ist eine Volumen -und Plasmasubstitution mit hydroxyathylstarke allein moglich?]. Anaesthesist 1990;39(7):353-60.
91. Wahba A, Sendtner E, Birnbaum DE. Fluid resuscitation with Haemaccel vs. human albumin following coronary artery bypass grafting. The Thoracic and Cardiovascular Surgeon 1996;44(4):178-83. [MEDLINE: 1997051433]
92. Watkins J, Wild G, Appleyard TN, Hardy G. Complement activation by polystarch and gelatine volume expanders. Lancet 1990;335(8683):233.
93. Hondebrink Y, Jeekel L, Oude Nijhuis J, Woittiez AJJ. Restoration of colloid osmotic pressure in hypoalbuminaemic patients. Intensive Care Medicine 1997;23(supp 1):S184.
94. Timmer B, Hondebrink Y, Oude Nijhuis J, Woittiez AJJ. Restoration of colloid osmotic pressure in hypoalbuminaemic patients. Netherlands Journal of Medicine 1998;52:A42.
95. Yang J, Wang WT, Yan LN, Xu MQ, Yang JY. Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: an open, randomized clinical trial of efficacy and safety. Chinese Medical Journal 2011;124(10):1458-64.
96. Boks RH, Wijers MJ, Hofland J, Takkenberg JJM, Bogers AJJ. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference?. Perfusion 2007;22(5):333-8. [DOI: 10.1177/0267659107086656]
97. Boldt J, Knothe C, Schindler E, Hammermann H, Dapper F, Hempelmann G. Volume replacement with hydroxyethyl starch solution in children. British Journal of Anaesthesia 1993;70(6):661-5.
98. Boldt J, Lehmann A, Rompert R, Haisch G, Isgro F. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anaesthesia 2000;14(3):264-8.
99. Boldt J, Schollhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anesthesia and Analgesia 2006;103:191-9.
100. Boldt J, Brosch C, Röhm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. British Journal of Anaesthesia 2008;100(4):457-64.
101. Brehme S, Keysser G, Turowski A, Schmidt H. Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte sodium over 48 hours [Hamorheologische wirkungen von hydroxyathylstarke 200/0.5, dextran 40, oxypolygelatine und vollelekttrolytlosung uber 48 studen]. Zeitschrift fur die Gesamte Innerve Medizin und ihre Grenzgebiete 1993;48(10):506-10.
102. Bremerich DH, Lischke V, Asskali F, Forster H, Behne M. Pharmacodynamics and tolerability of acetyl starch as a new plasma volume expander in patients undergoing elective surgery. International Journal of Clinical Pharmacology and Therapeutics 2000;38(8):408-14.
103. Charlet P, Zerr C, Robert D, Merville C, Renouf P, Khayat MC. Comparative trials of fluid gelatins on hemostasis in heart surgery in adults [Essais comparatifs des gelatines fluides sur l'hemostase dans la chirurgie cardiaque de l'adulte]. Cahiers d'Anesthesiologie 1991;39(4):233-8.
104. Christ F, Niklas M, Kreimeier U, Lauterjung L, Peter K, Messmer K. Hyperosmotic-hyperoncotic solutions during abdominal aortic aneurysm (AAA) resection. Acta Anaesthesiologica Scandinavica 1997;41(1):62-70.
105. Emery EF, Greenough A, Gamsu HR. Randomised controlled trial of colloid infusions in hypotensive preterm infants. Archives of Disease in Childhood, 1992;67(10(S)):1185-8.
106. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Anesthesia and Analgesia 1999;88(5):992-8.
107. Green RS, Zed PJ, McIntyre L. Pentastarch Resuscitation in Severe Sepsis and Septic Shock. Canadian Journal of Emergency Medicine 2010;12(1):58-61.
108. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. Journal of Cardiothoracic and Vascular Anesthesia 2001;15(3):316-21.
109. Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesthesia and Analgesia 2001;92(3):565-71. [MEDLINE: 21124037]
110. Hankeln K, Senker R, Beez M. Comparative study of the intraoperative effectiveness of 5% human albumin or 10% hydroxyethyl starch (HAES-steril) on hemodynamics and oxygen transport in 40 patients [Vergleichende Untersuchung zur intraoperativen Wirksamkeit von 5% Humanalbumin oder 10% Hydroxyathylstarke (HAES-steril) auf Hamodynamik und Sauerstofftransport bei 40 Patienten]. Infusionstherapie 1990;17(3):135-40.
111. Harke H, Thoenies R, Margraf I, Momsen W. The influence of different plasma substitutes on blood clotting and platelet function during and after surgery [Der Einfluss verschiedener Plasmaersatzmittel auf Gerinnungssystem und Thrombocytenfunktion wahrend und nach operativen Eingriffen. Vorlaufige Ergebnisse einer klinischen Studie]. Anaesthesist 1976;25(8):366-73.
112. Hiippala S, Teppo AM. Perioperative volume effect of HES 120/0.7 compared with dextran 70 and Ringer acetate. Annales Chirurgiae et Gynaecologiae 1996;85(4):333-9.
113. Hopkins PM. 6% Hydroxyethylstarch with 4% gelatine as peri-operative intravenous volume replacement in surgical patients. National Research Register Version 1/1998.
114. Huet RCGG, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JAM, van Oeveren W, et al. A novel hydroxyethyl starch (Voluven(TM)) for effective perioperative plasma volume substitution in cardiac surgery. Canadian Journal of Anaesthesia 2000;47(12):1207-15.
115. Huttner I, Boldt J, Haisch G, Suttner S, Kumle B, Schulz H. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. British Journal of Anaesthesia 2000;85(3):417-23.
116. Jones SB, Whitten CW, Monk TG. Influence of crystalloid and colloid replacement solutions on hemodynamic variables during acute normovolemic hemodilution. Journal of Clinical Anesthesia 2004;16(1):11-7.
117. Jovanovic K, Filipovic N, Romic P, Surbatovic M. Hetastarch in replacement of circulation volume compared to haemaccel and dextran 70 in pre-hospital resuscitation of polytraumatised patients. Intensive Care Medicine 1997;23:S184.
118. Korttila K, Grohn P, Gordin A, Sundberg S, Salo H, Nissinen E, et al. Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation. Journal of Clinical Pharmacology 1984;24(7):273-82.
119. Kotzampassi K, Grosomanidis V, Andreopoulos K, Skourtis CH, Eleftheriadis E. Albumin versus colloids in colon surgery patients: preliminary results (Abstract no P229). Critical Care 2008;12(Suppl 2):P229. [DOI: 10.1186/cc6450]
120. Langeron ODM, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4) causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesthesia and Analgesia 2001;92(4):855-62.
121. Palumbo. The effect of HES solution in critically ill patients. Minerva Anesthesiology 2006;72:655-64.
122. Puri VK, Howard M, Paidipaty B, Singh S. Resuscitation in hypovolemia and shock: a prospective study of hydroxyethyl starch and albumin. Critical Care Medicine 1983;11(7):518-23.
123. Rauch S, Sefrin P. Comparison of hydroxyethyl starch solutions derived from potato and corn starch [Vergleich von Hydroxyethylstarkelosungen aus Kartoffel- und Maisstarke]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 2000;35(12):750-5.
124. Rehm M, Orth V, Scheingraber S, Kreimeier U, Brechtelsbauer H, Finsterer U. Acid-base changes caused by 5% albumin versus 6% hydroxyethyl starch solution in patients undergoing acute normovolemic hemodilution: a randomized prospective study. Anesthesiology 2000;93(5):1174-83.
125. Romero J, Luna P, Fernandez B, Rojas E, Sarrano X, Alvarez H. The use of HAES-Steril 6% as a plasma expander after cardiopulmonary bypass in aortocoronary surgery [Uso de HAES esteril 6% como expansor plasmatico despues de la circulacion extracorporea en revascularizacion coronaria]. Revista Mexicana de Anestesiologia 1999;22:160-7.
126. Strauss RG, Stump DC, Henriksen RA, Saunders R. Effects of hydroxyethyl starch and fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 1985;25(3):230-4.
127. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiologica Belgica 2009;60:91-7.
128. Waxman K, Holness R, Tominaga G, Chela P, Grimes J. Hemodynamic and oxygen transport effects of pentastarch in burn resuscitation. Annals of Surgery 1989;209(3):341-5.
129. Yap WW, Young D, Pathi V. Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass - a randomised controlled trial. Perfusion 2007;22:57-61.
130. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
131. Armstrong RF, Bullen C, Cohen SL, Singer M, Webb AR. Critical care algorithms. Vol. Oxford Medical Publications, Oxford University Press, 1994.
132. Berlin JA. Does blinding of readers affect the results of meta-analyses?. Lancet 1997;350:185-6.
133. Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesthesia and Analgesia 1996;83:254-61.
134. Boldt J, Suttner S, Brosch C, Lehmann A, Roehm K, Mengitsu A. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesthesia and Analgesia 2009;109:1752-62.
135. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
136. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD000567.pub4]
137. Reinhart K, Takala J. Hydroxyethyl starches: what do we still know?. Anesthesia and Analgesia 2011;112:507-11.
138. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD001208.pub4]
139. Shafer SL. Shadow of doubt. Anesthesia and Analgesia 2011;112:498-500.
140. Traylor RJ, Pearl RG. Crystalloid versus colloid: all colloids are not created equal. Anesthesia and Analgesia 1996;83:209-12.
141. Vermeulen LC Jr, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Archives of Internal Medicine 1995;155(4):373-9.
142. Yim JM, Vermeyken LC, Erstad BL, Matuszewski KA, Burnett DA, Vlasses PH. Albumin and nonprotein colloid solution use in US academic health centers. Archives of Internal Medicine 1995;155(22):2450-5.